Konidaris Tasos

Track

Insider profile

Performance

Overall performance
1.7
Performance over holding periods
1.7
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 16% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Konidaris Tasos's trades of Amneal Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
480.11
Quantity 24,219
Value US$185,176
Transaction date
Proposed sale
Price
9.27
Quantity 169,206
Value US$1,568,539
Transaction date
Proposed sale
Price
9.02
Quantity 111,635
Value US$1,006,947
Transaction date
Proposed sale
Price
8.84
Quantity 100,000
Value US$884,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-08-15 2025-08-15
PrS Proposed sale
24,219
480.11
US$185,176 		24,219 480.11 US$185,176
2025-08-15 2025-08-15
S Sale
2,793 +39.8%
17.22
US$2,757,978 		2,793 +39.8% 17.22 US$2,757,978
2025-08-15 2025-08-14
S Sale
39,237 -19.3%
16.37
US$2,539,368 		39,237 -19.3% 16.37 US$2,539,368
2025-08-15 2025-08-13
S Sale
161,365 -25.9%
9.22
US$1,487,785 		161,365 -25.9% 9.22 US$1,487,785
2025-08-13 2025-08-13
PrS Proposed sale
169,206
9.27
US$1,568,539 		169,206 9.27 US$1,568,539
2025-08-13 2025-08-13
PrS Proposed sale
111,635
9.02
US$1,006,947 		111,635 9.02 US$1,006,947
2025-03-07 2025-03-05
S Sale
100,000 -13.9%
8.91
US$891,000 		100,000 -13.9% 8.91 US$891,000
2025-03-05 2025-03-05
PrS Proposed sale
100,000
8.84
US$884,000 		100,000 8.84 US$884,000